These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23212943)

  • 41. Neuromedin U enhances proliferation of ACTH-stimulated adrenocortical cells in the rat.
    Trejter M; Guidolin D; Nowak M; Macchi V; Majchrzak M; De Caro R; Malendowicz LK
    Int J Mol Med; 2009 Jan; 23(1):99-104. PubMed ID: 19082512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postnatal developmental of Neuromedin S and its receptor in the male Xiaomeishan pig reproductive axis.
    Ma Z; Zhao Y; Yao Y; Lei Z; Jin M; Li X; Jia C; Zhang Z; Li X; Su J
    Anim Reprod Sci; 2017 Jun; 181():115-124. PubMed ID: 28389048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.
    Takayama K; Mori K; Asari T; Sohma Y; Nomura E; Sasaki Y; Taguchi A; Taniguchi A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127436. PubMed ID: 32721452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromedin U and its receptors: structure, function, and physiological roles.
    Brighton PJ; Szekeres PG; Willars GB
    Pharmacol Rev; 2004 Jun; 56(2):231-48. PubMed ID: 15169928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
    Ju X; Nagashima A; Dvorkin-Gheva A; Wattie J; Howie K; Whetstone C; Ranjbar M; Cusack R; Ditta R; Paré G; Satia I; O'Byrne PM; Gauvreau GM; Sehmi R
    Am J Respir Crit Care Med; 2024 Sep; 210(6):755-765. PubMed ID: 38598774
    [No Abstract]   [Full Text] [Related]  

  • 46. Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1.
    Takayama K; Mori K; Sasaki Y; Taguchi A; Taniguchi A; Miyazato M; Hayashi Y
    ACS Med Chem Lett; 2024 Jun; 15(6):885-891. PubMed ID: 38894927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.
    Takayama K; Mori K; Sohma Y; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
    ACS Med Chem Lett; 2015 Mar; 6(3):302-7. PubMed ID: 25815150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of receptors for neuromedin U and its role in feeding.
    Howard AD; Wang R; Pong SS; Mellin TN; Strack A; Guan XM; Zeng Z; Williams DL; Feighner SD; Nunes CN; Murphy B; Stair JN; Yu H; Jiang Q; Clements MK; Tan CP; McKee KK; Hreniuk DL; McDonald TP; Lynch KR; Evans JF; Austin CP; Caskey CT; Van der Ploeg LH; Liu Q
    Nature; 2000 Jul; 406(6791):70-4. PubMed ID: 10894543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.
    Aiyar N; Disa J; Foley JJ; Buckley PT; Wixted WE; Pullen M; Shabon U; Dul E; Szekeres PG; Elshourbagy NA; Sarau HM; Appelbaum E; Bolaky J
    Pharmacology; 2004 Sep; 72(1):33-41. PubMed ID: 15292653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A chemically stable peptide agonist to neuromedin U receptor type 2.
    Takayama K; Mori K; Tanaka A; Sasaki Y; Sohma Y; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
    Bioorg Med Chem; 2020 May; 28(10):115454. PubMed ID: 32247748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.
    Malendowicz LK; Ziolkowska A; Rucinski M
    Front Endocrinol (Lausanne); 2012; 3():156. PubMed ID: 23227022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuromedin-U inhibits unilateral adrenalectomy-induced compensatory adrenal growth in the rat.
    Malendowicz LK; Guidolin D; Trejter M; Rucinski M; Porzionato A; de Caro R; Nowak M
    Peptides; 2009 May; 30(5):935-9. PubMed ID: 19428772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine.
    Li Y; Liu S; Zhou K; Wang Y; Chen Y; Hu W; Li S; Li H; Wang Y; Wang Q; He D; Xu H
    Science; 2023 Sep; 381(6663):1189-1196. PubMed ID: 37708282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus.
    Qiu DL; Chu CP; Tsukino H; Shirasaka T; Nakao H; Kato K; Kunitake T; Katoh T; Kannan H
    Neurosci Lett; 2005 Feb; 374(1):69-72. PubMed ID: 15631899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.
    Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M
    J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system.
    Mitchell JD; Maguire JJ; Kuc RE; Davenport AP
    Cardiovasc Res; 2009 Feb; 81(2):353-61. PubMed ID: 18987052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).
    Kojima M; Haruno R; Nakazato M; Date Y; Murakami N; Hanada R; Matsuo H; Kangawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):435-8. PubMed ID: 11027493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system.
    Nakahara K; Hanada R; Murakami N; Teranishi H; Ohgusu H; Fukushima N; Moriyama M; Ida T; Kangawa K; Kojima M
    Biochem Biophys Res Commun; 2004 May; 318(1):156-61. PubMed ID: 15110767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.